Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes.
J Thromb Thrombolysis
; 53(2): 363-371, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-35041121
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thrombosis
/
Diabetes Mellitus
/
COVID-19
/
COVID-19 Drug Treatment
/
Hypoglycemic Agents
/
Metformin
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Thromb Thrombolysis
Journal subject:
ANGIOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands